Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids

Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids

Gastroenteropancreatic neuroendocrine tumors (GEP-NET) account for roughly 60% of all neuroendocrine tumors. Low/intermediate grade human GEP-NETs have relatively low proliferation rates that animal models and cell lines fail to recapitulate. Short-term patient-derived cancer organoids (PDCOs) are a...

Full description

Bibliographic Details
Main Authors: Amani A. Gillette, Christopher P. Babiarz, Ava R. VanDommelen, Cheri A. Pasch, Linda Clipson, Kristina A. Matkowskyj, Dustin A. Deming, Melissa C. Skala
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
fluorescence lifetime imaging
NAD(P)H
autofluorescence
neuroendocrine tumor
organoid
Online Access:https://www.mdpi.com/2072-6694/13/8/1873

Internet

https://www.mdpi.com/2072-6694/13/8/1873

Similar Items